How many insider trades does FilingIQ track for OTLC?

FilingIQ tracks 31 Form 4 insider transactions for OTLC (Oncotelic Therapeutics, Inc.), covering filings from Mar 31, 2021 onwards. 2 of those were filed in the last 90 days.

Are OTLC insiders net buyers or net sellers?

Across the full Form 4 history for OTLC, 20 transactions (65%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OTLC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OTLC in?

Oncotelic Therapeutics, Inc. (OTLC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $16.38M.

OTLC insider trading

OTC Markets OTCQB Healthcare

Oncotelic Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

65% / 0%

Market cap

$16.38M

About Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications. It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, it develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson's disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatments of various cancers. The company is based in Agoura Hills, California.

Company website: www.oncotelic.com

OTLC insider activity at a glance

FilingIQ has scored 31 insider transactions for OTLC since Mar 31, 2021. The most recent filing in our index is dated Jun 17, 2026.

Across the full history, 20 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OTLC insider trades is 59.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OTLC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,204

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 159

Guardant Health, Inc.

First Tracks Biotherapeutics, Inc.

KALV 133

KalVista Pharmaceuticals, Inc.

Frequently asked

How many insider trades does FilingIQ track for OTLC?: FilingIQ tracks 31 Form 4 insider transactions for OTLC (Oncotelic Therapeutics, Inc.), covering filings from Mar 31, 2021 onwards. 2 of those were filed in the last 90 days.
Are OTLC insiders net buyers or net sellers?: Across the full Form 4 history for OTLC, 20 transactions (65%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OTLC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OTLC in?: Oncotelic Therapeutics, Inc. (OTLC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $16.38M.

Methodology & sources

Every OTLC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.